Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 2139 results found since Jan 2013.

Human Papillomavirus Vaccination Uptake in Canada: A Systematic Review and Meta ‑analysis
The objectives of this study are twofold and aim to (1) determine the levels and (2) examine the various factors in fluencing vaccine uptake among the general Canadian population. A literature search was conducted on seven databases, followed by screening, methodological quality review (using modifed Newcastle‑Ottawa Scale), and data extraction. Pooled meta‑analysis and a subgroup analysis were conducted str atifying by a number of variables (age, sex, type of program, and method of payment) determinedapriori. A total of 718 peer ‑reviewed articles were initially identifed with 12 remaining after screening and under...
Source: International Journal of Preventive Medicine - September 10, 2017 Category: International Medicine & Public Health Source Type: research

Public health approach to prevent cervical cancer in HIV-infected women in Kenya: Issues to consider in the design of prevention programs
Publication date: Available online 16 October 2017 Source:Gynecologic Oncology Reports Author(s): Menon Sonia, Rossi Rodolfo, Stacy G. Harmon, Hillary Mabeya, Steven Callens Women living with HIV in Africa are at increased risk to be co-infected with Human Papilloma Virus (HPV), persistent high risk (HR) HPV infection and bacterial vaginosis (BV), which compounds HPV persistence, thereby increasing the risk for cervical dysplasia. New guidance from WHO in 2014 advocating for a “screen and treat” approach in resource poor settings is becoming a more widely recommended screening tool for cervical cancer prevention progr...
Source: Gynecologic Oncology Reports - October 16, 2017 Category: OBGYN Source Type: research

Herpes Simplex Virus Glycoprotein D Targets a Specific Dendritic Cell Subset and Improves the Performance of Vaccines to Human Papillomavirus-Associated Tumors
Cervical cancer is a major public health problem and one of the leading causes of cancer deaths in women. Virtually all cases of cervical cancer, as well as a growing share of anal and head/neck tumors, are associated with human papillomavirus (HPV) infection. Despite the effectiveness, the available prophylactic vaccines do not benefit women with cervical lesions or cancer. Therefore, the search of new immunotherapeutic approaches to treat HPV-induced tumors is still a priority. The present study characterizes a therapeutic antitumor vaccine based on the genetic fusion of the Herpes simplex virus-1 (HSV-1) glycoprotein D ...
Source: Molecular Cancer Therapeutics - September 4, 2017 Category: Cancer & Oncology Authors: Porchia, B. F. M. M., Moreno, A. C. R., Ramos, R. N., Diniz, M. O., de Andrade, L. H. T. M., Rosa, D. S., Barbuto, J. A. M., Boscardin, S. B., Ferreira, L. C. S. Tags: Large Molecule Therapeutics Source Type: research

Safety of Human Papillomavirus Vaccines: An Updated Review
AbstractHuman papillomavirus (HPV) vaccines are now included in immunisation programmes in 71 countries. Unfortunately, uptake has been impacted in some countries by reduced confidence in the safety of the HPV vaccine. In 2013, we published an extensive review demonstrating a reassuring safety profile for bivalent (2vHPV) and quadrivalent (4vHPV) vaccines. A nonavalent (9vHPV) vaccine is now available and HPV immunisation programmes have been extended to males in 11 countries. The aim of this updated narrative review was to examine the evidence on HPV vaccine safety, focusing on the 9vHPV vaccine, special populations and a...
Source: Drug Safety - December 26, 2017 Category: Drugs & Pharmacology Source Type: research

Strengthening the case for gender-neutral and the nonavalent HPV vaccine
ConclusionGender-neutral vaccination provides significant cost-effective benefits for preventing human papillomavirus-related diseases, and this effect is further enhanced by the use of the nonavalent vaccine.
Source: European Archives of Oto-Rhino-Laryngology - January 11, 2018 Category: ENT & OMF Source Type: research

Current research into novel therapeutic vaccines against cervical cancer.
Authors: Cordeiro MN, de Lima RCP, Paolini F, Melo ARDS, Campos APF, Venuti A, de Freitas AC Abstract INTRODUCTION: Cervical cancer and cervical intraepithelial neoplasia (CIN) are well-known outcomes of a human papillomavirus (HPV) infection. Viral oncogenes expressions like E6, E7, and, recently recognized E5, lead to HPV-related malignant progression. Although HPV prevention by powerful vaccines against most frequent and oncogenic genotypes is feasible, current treatment against cervical neoplasia is distant from an ideal one. In addition, late diagnosis is commonly associated with a poor prognosis. On top of th...
Source: Expert Review of Anticancer Therapy - February 25, 2018 Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research

Evaluation of Pediatric Human Papillomavirus Vaccination Provider Counseling Written Materials: A Health Literacy Perspective
Conclusions Few written materials for HPV vaccination counseling were optimal from a health literacy best practices perspective. Content comprehensiveness was important for informed decision making.
Source: Academic Pediatrics - March 1, 2018 Category: Pediatrics Source Type: research

Global human papilloma virus vaccine implementation: An update
The objective of this narrative review is to provide an update on the current status of HPV vaccination worldwide. This will be helpful for clinicians in counseling parents and guardians as this vaccine mainly targets sexually naïve preadolescents. An electronic search of the databases was carried out to retrieve information concerning HPV vaccine implementation between July 2006 and 2017, with special emphasis on the current viewpoints, controversies and ethical issues. Globally, 74 countries have implemented the HPV vaccine in the national immunization schedule, and this vaccine is listed as an essential medicine by WHO...
Source: Journal of Obstetrics and Gynaecology Research - March 8, 2018 Category: OBGYN Authors: Sasidharanpillai Sabeena, Parvati V. Bhat, Veena Kamath, Govindakarnavar Arunkumar Tags: Review Source Type: research

Figure Caption Correction: Characteristics of Articles About Human Papillomavirus Vaccination in Japanese Newspapers: Time-Series Analysis Study
This study aimed to identify mentions of cervical cancer vaccine in Japan’s printed news media and to determine their characteristics. We used the archival databases of 2 Japanese newspapers, Yomiuri Shimbun (Yomidasu Rekishikan) and Asahi Shimbun (Kikuzo II Visual), for text mining. First, we created a database by extracting articles published between January 1, 2007, and December 31, 2014, that matched the terms “cervical cancer” AND “vaccination” in a keyword search. Then, we tallied the extracted articles based on the month of publication and number of characters in order to conduct a time-series analysis. We...
Source: Journal of Medical Internet Research - March 16, 2018 Category: General Medicine Authors: Nao Ueda Ryoki Yokouchi Taro Onoda Atsushi Ogihara Source Type: research

A bibliometric analysis of systematic reviews on vaccines and immunisation.
CONCLUSIONS: SYSVAC provides a freely searchable platform to identify existing vaccine-policy-relevant systematic reviews. Systematic reviews will need to be assessed adequately for each specific question and quality. PMID: 29576305 [PubMed - as supplied by publisher]
Source: Vaccine - March 22, 2018 Category: Allergy & Immunology Authors: Fernandes S, Jit M, Bozzani F, Griffiths UK, Scott JAG, Burchett HED Tags: Vaccine Source Type: research

Human Papillomavirus Vaccine Uptake, Knowledge, and Acceptance for Youth: A Systematic Review of Appalachia
AbstractThough vaccine uptake and public support have risen since the release of the first HPV vaccines, the United States has far lower initiation and completion rates for the HPV vaccine series in comparison to other vaccines indicated for youth. Disparities are even greater in the Appalachian regions. Understanding factors contributing to these discrepancies is vital to improving vaccine rates in Appalachia. A comprehensive literature search identified all articles pertaining to HPV vaccination in children and adolescents living in Appalachia. The final 15 articles were included in a systematic review of the topic.
Source: Journal of Community Health - April 26, 2018 Category: International Medicine & Public Health Source Type: research

Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review.
Conclusions: An examination of the region collectively offers an insight into the willingness of the general population and healthcare providers to receive more information about the virus and prevention of infection through vaccination. This review suggests that the vaccine acceptability would be high once cost concerns are resolved. PMID: 30079949 [PubMed - in process]
Source: Eastern Mediterranean Health Journal - August 11, 2018 Category: Middle East Health Tags: East Mediterr Health J Source Type: research

Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials.
CONCLUSIONS: Treatment with therapeutic vaccines is a promising and seemingly safe strategy for patients with HPV+ head and neck cancer. However, there are not enough data to draw any further conclusions and clinical outcome measures and tumour responses to the vaccines are still missing. PMID: 30268734 [PubMed - as supplied by publisher]
Source: Vaccine - September 26, 2018 Category: Allergy & Immunology Authors: Schneider K, Grønhøj C, Hahn CH, von Buchwald C Tags: Vaccine Source Type: research

IJERPH, Vol. 15, Pages 2210: Prevalence and Risk Factors of Human Papillomavirus in Male Patients: A Systematic Review and Meta-Analysis
In conclusion, the prevalence of HPV in men is high. The risk factors for HPV infection are sexual promiscuity, early sexual debut, absence of circumcision, lack of condom use and smoking. Further study in this field about the effectiveness of the vaccine and health education should be conducted.
Source: International Journal of Environmental Research and Public Health - October 10, 2018 Category: Environmental Health Authors: Mar ía Inmaculada Rodríguez-Álvarez Jose L. G ómez-Urquiza Husein Husein-El Ahmed Luis Albend ín-García Juan G ómez-Salgado Guillermo A. Ca ñadas-De la Fuente Tags: Review Source Type: research

A review of knowledge and attitudes of young people on cervical cancer and HPV vaccination
ConclusionCervical cancer is potentially preventable. Effective screening and education programs with regard to human papillomavirus vaccination and infection can lead to a significant reduction in morbidity and mortality.
Source: Journal of Public Health - January 7, 2019 Category: Health Management Source Type: research